Results 31 to 40 of about 179,557 (197)
Two high-risk susceptibility loci at 6p25.3 and 14q32.13 for Waldenström macroglobulinemia
Waldenström macroglobulinemia (WM)/lymphoplasmacytic lymphoma (LPL) is a non-Hodgkin-type B cell lymphoma. Here, the authors identify two risk loci for WM/LPL in a two-stage GWAS involving a family-oversampling approach and provide evidence for a ...
Mary L. McMaster +80 more
doaj +1 more source
There are emerging data to support a role for genetic and immune-related factors in the pathogenesis of lymphoplasmacytic lymphoma/Waldenstrom's macroglobulinemia.
Kristinsson, Sigurdur Y. +13 more
core +1 more source
Pleural effusion is a rare complication of lymphoplasmacytic lymphoma. When it occurs, traditional investigation techniques may not always be successful.
Emanuele Stirpe +2 more
doaj +1 more source
DNA methylation in follicular lymphoma [PDF]
PhDFollicular Lymphoma (FL) is a common B cell Non-Hodgkin Lymphoma with a median survival of 8-10 years. Patients frequently undergo transformation to a more aggressive lymphoma and this is associated with drastically reduced survival.
Ó Riain, Ciarán Liam
core +4 more sources
Lymphoplasmacytic lymphoma and marginal zone lymphoma: diagnostic challenges
non ...
SA Pileri +3 more
doaj +4 more sources
Dang Nguyen Van,1,2 Nghia Duong Van,1 Quang Le Van,1 Tung Ngo Thanh,2 To Ta Van3 1Department of Oncology, Hanoi Medical University, Hanoi, Vietnam; 2Department of Head and Neck Radiation Oncology, Vietnam National Cancer Hospital, Hanoi, Vietnam; 3Center
Nguyen Van D +4 more
doaj
Summary Second primary cancers (SPCs) are a survivorship concern in lymphoplasmacytic lymphoma/Waldenström macroglobulinaemia (LPL/WM), but estimates may be influenced by competing mortality and surveillance. We assessed cumulative incidence, relative risk and predictors of SPCs. We studied 521 patients diagnosed with LPL/WM in Region Zealand, Denmark,
Lars Munksgaard +2 more
wiley +1 more source
Waldenström macroglobulinemia (WM)/lymphoplasmacytic lymphoma (LPL) is often differentiated from myeloma based on the presence of lytic bone lesions (LBL). However, WM/LPL can present with LBL, and management is poorly understood.
Mizba Baksh +8 more
doaj +1 more source
ABSTRACT Aberrant expression of T‐cell markers in B‐cell lymphomas is rare and can pose diagnostic challenges. We report a case of a 65‐year‐old man presenting with newly developed scalp nodules. Histopathology revealed nodular lymphoid infiltrates composed of large centrocytes and centroblasts.
V. Pfefferle +4 more
wiley +1 more source
Prevalence and Disability of Peripheral Neuropathy in Patients With Waldenström's Macroglobulinemia
ABSTRACT Objectives Peripheral neuropathy (PN) is considered a frequent complication of Waldenström's macroglobulinemia (WM). Establishing a causal relationship between PN and WM is complicated by confounding factors such as age‐related axonal loss and diabetes. This scoping review aims to summarize the current evidence on WM‐associated PN with a focus
Morten Müller Aagaard +6 more
wiley +1 more source

